Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Transforming Growth Factor β1 Increases p27 Levels via Synthesis and Degradation Mechanisms in the Hyperproliferative Gastric Epithelium in Rats

  • Ana P. Z. P. Fiore,

    Affiliation Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, SP Brazil

    ⨯
  • Luciana H. Osaki,

    Affiliation Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, SP Brazil

    ⨯
  • Patricia Gama

    patgama@usp.br

    Affiliation Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, SP Brazil

    ⨯

Abstract

Throughout postnatal development, the gastric epithelium expresses Transforming Growth Factor beta1 (TGFβ1), but it is also exposed to luminal peptides that are part of milk. During suckling period, fasting promotes the withdrawal of milk-born molecules while it stimulates gastric epithelial cell proliferation. Such response can be reversed by exogenous TGFβ1, as it directly affects cell cycle through the regulation of p27 levels. We used fasting condition to induce the hyperproliferation of gastric epithelial cells in 14-day-old Wistar rats, and evaluated the effects of TGFβ1 gavage on p27 expression, phosphorylation at threonine 187 (phospho-p27Thr187) and degradation. p27 protein level was reduced during fasting when compared to suckling counterparts, while phospho-p27Thr187/p27 ratio was increased. TGFβ1 gavage reversed this response, which was confirmed through immunostaining. By using a neutralizing antibody against TGFβ1, we found that it restored the p27 and phosphorylation levels detected during fasting, indicating the specific role of the growth factor. We noted that neither fasting nor TGFβ1 changed p27 expression, but after cycloheximide administration, we observed that protein synthesis was influenced by TGFβ1. Next, we evaluated the capacity of the gastric mucosa to degrade p27 and we recorded a higher concentration of the remaining protein in pups treated with TGFβ1, suggesting augmented stability under this condition. Thus, we showed for the first time that luminal TGFβ1 increased p27 levels in the rat gastric mucosa by up- regulating translation and reducing protein degradation. We concluded that such mechanisms might be used by rapidly proliferating cells to respond to milk-born TGFβ1 and food restriction.

Citation: Fiore APZP, Osaki LH, Gama P (2014) Transforming Growth Factor β1 Increases p27 Levels via Synthesis and Degradation Mechanisms in the Hyperproliferative Gastric Epithelium in Rats. PLoS ONE 9(7): e101965. https://doi.org/10.1371/journal.pone.0101965

Editor: François Blachier, National Institute of Agronomic Research, France

Received: March 20, 2014; Accepted: June 13, 2014; Published: July 7, 2014

Copyright: © 2014 Fiore et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper.

Funding: This study was funded by Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP 2008/05393-2; 2011/17415-3). APZPF was recipient of CAPES PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Transforming growth factor β (TGFβ) is part of super family of peptides [1] that function in different tissue contexts to control development, growth and tumorigenesis [2]. In the gastrointestinal tract, TGFβ isoforms regulate epithelial renewal through effects on cell proliferation [3]–[7], differentiation [8], [9], epithelial mesenchymal transition [10], [11], migration [12], and apoptosis [13]. TGFβ has been detected in human and murine milk [14], [15] and after suckling and oral administration, signaling is activated in gastric epithelial cells through receptors (TβRI and TβRII) and Smads central cascade [6], [15]–[17].

Previous studies showed that the components of TGFβ pathway can be altered in gastric tumorigenesis and they act differently depending on cancer stage, in a way that during early events, TGFβ regulates proliferation, whereas lately, it induces invasion and metastasis [7], [11], [18], [19]. TGFβ is also among the many molecules that take part of the complex ontogenesis of gastric mucosa [8], [20]–[22], and we demonstrated that soon after the gavage of suckling rats with TGFβ1, R-Smads are rapidly phosphorylated and increase the concentration of p27, which leads to cell proliferation inhibition in the stomach [6].

p27 belongs to the Cip/Kip family of peptides (cyclin-dependent kinase inhibitors, CKI) that regulate cell cycle progression. Either the loss of p27 or its low concentration increase turnover rates, which are associated with poor prognosis for tumours, including the gastric cancers [23]–[25]. p27 levels oscillate during cell cycle, and this variation is coordinated mainly by post- translational mechanisms [26]. Accordingly, phosphorylation of specific aminoacids and cellular localization determine the role of p27 on proliferation, cell organization, phenotype and migration. The phosphorylation at threonine 187 (Thr187) by CyclinE/Cdk2 complex is a first step for proteasomal degradation [26]–[28]. Nuclear phospho-p27Thr187 is recognized by S-phase-kinase-associated protein 2 (Skp2) from SCF complex to be ubiquitylated and degraded [29]–[33]. In epithelial cells, TGFβ signaling targets p27 for stability [6], [34]–[36], and such effect is mediated by TGFβ induction of Skp2 degradation [37].

Because milk-born TGFβ as well as the isoforms expressed by the gastric mucosa are directly involved in the control of epithelium proliferation both during development and tumorigenesis, and p27 plays a central role in cell cycle control, we currently aimed to evaluate the molecular mechanisms involved in the regulation of gastric p27 levels by TGFβ. More specifically, we used fasting condition to induce the hyperproliferation of epithelial cells [6], [38], [39], and evaluated the effects of TGFβ1 gavage on p27 expression, synthesis, phosphorylation at threonine 187 and degradation in the rat gastric mucosa. We found that luminal TGFβ1 increased p27 levels by up- regulating translation and reducing protein degradation, and we suggest that such mechanisms could be used by gastric epithelial cells to respond to milk-born TGFβ1 and food restriction. Therefore, we consider that our results add relevant data to studies on nutrition and development, and as importantly, to others that focus on gastric cancer therapy.

Materials and Methods

Animals

Wistar rats from the Department of Cell and Developmental Biology Animal Colony (ICB USP) were used. This study was approved by the Ethical Committee in Animal Use (CEUA protocol 8014/2011) from the Institute of Biomedical Sciences at the University of Sao Paulo. The anesthesia was conducted with a 1∶1 mixture of xilazine and ketamine chloridrates (0.5 ml/100 g body weight, Vetbrands, São Paulo, Brazil), and pups were euthanized with the excess of these drugs. Animals were kept at controlled conditions of temperature, humidity and light/dark cycle (12∶12 h). On the 3rd postnatal day, litters were reduced to 8–9 pups, which were kept with their dams until day 14, when half of the group was separated into aluminium cages to be fasted [6], [40]. Water was offered ad libitum. Different litters were used simultaneously to allow the random assignment to experimental groups. Pups were initially fasted for 90 min [6] and treated as described below, while control fed groups remained with dams.

The TGFβ1 (Peprotech, Rocky Hill, USA) was reconstituted in 4 mM HCl containing 0.1% bovine serum albumin (BSA) according to manufacturer's directions and it was further diluted in Phosphate Buffer Saline (PBS) containing 0.2 mg/ml BSA immediately before use. TGFβ1 solution or vehicle was administered by gavage in a single dose 90 min after the onset of fasting (1.5 ng/g body weight), and such procedure was performed according to previous studies [6], [41]. Gastric samples were collected immediately (0 h) or after 2 and 14 h of TGFβ1 or PBS treatment.

The specific effects of TGFβ1 were also tested through its inhibition by using a monoclonal antibody directed to this isoform (α-TGFβ1, R&D, Minneapolis, USA), which was administrated (30 ng/g body weight) [42] together with the peptide. Gastric samples were collected after 2 h of PBS, TGFβ1, α-TGFβ1 and TGFβ1 combined to α-TGFβ1 treatment.

In order to evaluate if TGFβ1 affected protein synthesis, pups were injected with cycloheximide (Biomol, Plymouth, USA) (i.p. injections to a total of 0.3 µg/g body weight) [43] using a first shot 60 min after fasting onset and a second shot immediately after PBS and TGFβ1 gavage. Samples from the gastric mucosa were collected after 2 h of treatment.

The stomach was excised and opened along the lesser curvature under anaesthesia with a 1∶1 mixture of xilazine and ketamine chloridrates (0.5 ml/100 g body weight, Vetbrands, São Paulo, Brazil), and pups were euthanized with the excess of these drugs. The gastric wall was stretched with the mucosal side up and flushed with a 0.9% saline solution for the specific collections described below.

RT-PCR

For the total RNA extraction, the gastric mucosa was scraped after 2 h of PBS or TGFβ1 gavage and rapidly frozen in liquid nitrogen. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, USA), according to manufacturer's directions. The cDNA was generated using 1 µg of RNA in the presence of 2.0 µl of Oligo dT (50 mM), 1.0 µl of dNTP mix (10 mM), 1.0 µl of DTT (100 mM), 2.0 µl of reverse transcription buffer (×10), and 1.0 µl of SuperScript III reverse transcriptase (200 U/µl) (all reagents from Invitrogen) to a total volume of 20 µl. The RT-PCR was performed as follows: incubation at 65°C (5 min) for Oligo dT annealing with the RNA, Superscript III reaction at 50°C (50 min) and inactivation of the enzyme at 85°C (5 min).

For the semi-quantitative PCR, 100 ng of each cDNA, 0.4 µl of dNTP mix (1 mM), 0.6 µl of MgCl2 (50 mM), 2.0 µl of polymerase buffer (10×) and 0.2 µl of Taq DNA polymerase (5 U/µl) (all reagents from Invitrogen) were incubated with 0.5 µl of each primer for p27 (10 µM FW: ACG CCA GAC GTA AAC AGC TC, RV: TCC AAT GCT TTT AGA GGC AGA for 30 cycles). As endogenous control, we used 0.5 µl of β-actin primers (10 µM, FW: CTG GGT ATG GAA TCC TGT GG, RV: AGG AGC CAG GGC AGT AAT CT for 23 cycles). The PCR was conducted as: denaturation (30 sec at 94°C), annealing (30 sec at 55°C) and extension (45 sec at 72°C) in thermocycler (Eppendorf, Hamburg, Germany).

Immunohistochemistry

For immunohistochemistry, stomachs were fixed in 10% formaldehyde, embedded in paraffin and non-serial 6 µm tissue sections were placed on positively charged slides (Fisherbrand, Kennesaw, USA). Sections were cleared of paraffin, rehydrated and peroxidase activity and nonspecific binding were blocked with 0.15% H2O2 (Sigma, Saint Louis, USA) in methanol and 5% rabbit serum (Jackson Laboratories, West Grove, USA), respectively. Antigen retrieval was performed with citric acid (pH 6.0) in microwave (5 min at high power followed by 3×3 min at medium power), followed by incubation with polyclonal anti-phospho-p27Thr187 (2.5 µg/ml, overnight at 4°C, Invitrogen). After the addition of biotinylated-goat anti-rabbit secondary antibody (Jackson Laboratories), the peroxidase activity was developed using 0.05% 3,3′-diaminobenzidine (DAB) (DAKO, Carpinteria, USA) in 50 mM Tris containing 3% H2O2 and slides were counterstained with Mayer's hematoxylin. Negative controls were incubated with normal serum to replace the primary antibody.

In order to estimate the epithelial population immunolabeled for phospho-p27Thr187, we identified the first parietal cell to determine the limit between foveolae and the gastric gland, and then tracked the epithelial cells along the entire gland. We counted the nuclei immunostained or not in a total of 1,200 cells per animal. The labeling index (LI) was obtained as the number of phospho-p27Thr187 positive cells/total cells ×100. Sections were observed under light microscope at ×800 (Nikon, Tokyo, Japan) and images were captured in light microscope at ×200 (Olympus, Montreal, Canada) using Image ProPlus v.5.2 (Media Cybernetics, Bethesda, USA).

Protein extraction

For protein extraction, the gastric mucosa was scraped and stored in 10 mM PMSF (Merck, Darmstadt, Germany) in 20 mM Tris buffered saline (TBS) at −80°C. Samples were homogenized in lysis buffer (20 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP40 and 10% glycerol) [44] containing a cocktail of protease and phosphatase inhibitors (1 mM PMSF, 1 mM benzamidin, 1 mM leupeptin; 1 mM aprotinin and 1 mM Na3VO4, Sigma). Homogenates were centrifuged at 12,000 g (5 min at 4°C), the supernatant was collected and whole protein concentration measured by Bradford method [45].

p27 degradation assay

In order to determine p27 degradation rate during fasting and TGFβ1 treatment, pups were fasted for 90 min and gavaged with PBS or TGFβ1 as described above. After 2 h of treatment the samples were collected by scraping and frozen in liquid nitrogen. The assay was performed as previously described [34], in order to test how long the gastric mucosa extracts would take to degrade recombinant p27 under each experimental condition. Briefly, each sample was re-suspended in a buffer containing 50 mM Tris (pH 8.3), 5 mM MgCl2, 1 mM DTT and protease inhibitors (1 mM aprotinin, 1 mM PMSF, e 1 mM leupeptin). After the complete homogenization, lysates were centrifuged at 10,000 g for 10 min. Protein concentration was determined by Bradford method and then the extracts (200 µg) were mixed with 60 µl of degradation buffer (the same above containing 2 mM ATP) in the presence of 1 µg of recombinant p27 (AbCam, Cambridge, USA) (Pagano et al., 1995). After different intervals (1 min, 30 min, 3 h, 6 h, and 20 h), aliquots of 10 µl (approximately 30 µg) were re-suspended in 20 µl of sample buffer (0.5M Tris, 10% SDS, 1% Bromophenol Blue, 0.1% β- mercaptoethanol) to stop the reaction, and then each vial was frozen in liquid nitrogen.

Western blotting

Thirty µg of protein extract were boiled in the sample buffer above, fractionated by 12% SDS-PAGE and then transferred to nitrocellulose membrane (Hybond, GE Healthcare, Buckinghamshire, UK). Proteins were detected by 0.5% Ponceau Red solution, the membrane was washed in 20 mM TBS (pH 7.4) and blocked in TBS containing 0.1% Tween 20 and 5% non-fat dry milk or 1% BSA. We incubated the membranes with monoclonal antibodies against p27 (0.3 µg/ml), Cdh1 (0.2 µg/ml, Calbiochem, Billerica, USA), and polyclonal antibodies against phospho-p27Thr187 (0.2 µg/ml, AbCam), cyclin E, Cdk2, and Skp2 (0.2 µg/ml, Santa Cruz Biotechnology). Monoclonal antibody for β-actin (0.01 µg/ml, Sigma) was used as an internal control. Bands were detected using ECL system (GE Healthcare), and the integrated optical densities (arbitrary units) were determined by Image J (1.37v Software, NIH Public Domain, USA) for the different proteins, which were compared to β-actin before fold-change calculation in each experiment.

Statistical analyses

Results were analyzed using ANOVA followed by Tukey's test to evaluate the effects of TGFβ1 treatment. Student's t test was used to compare controls and TGFβ1- treated groups at each interval during degradation assay. Significance level was set at P<0.05.

Results

Fasting and TGFβ1 effects on p27 levels and phosphorylation at threonine 187

We have previously shown that gavage with TGFβ1 increases p27 levels and inhibits gastric cell proliferation induced by fasting condition during postnatal development [6], [38]–[40]. Currently, we investigated whether this effect is dependent on the regulation of p27 levels at synthesis and degradation steps.

We first compared the total concentration and the phosphorylation of p27 at threonine 187. We observed that during food restriction, total p27 levels were reduced when compared to the suckling (control) group (P<0.05) (Fig. 1A), and this effect was continuous, as after 14 h of treatment p27 remained low. TGFβ1 administration reversed such response, in a way that 2 h after gavage, we detected a concentration of p27 higher than its corresponding control (P<0.05) and also increased when compared to the suckling group (P<0.05) that received milk-born TGFβ1. After 14 h, we observed that TGFβ1 effect was maintained, as p27 level was still elevated when the results obtained for pups treated with PBS were considered (P<0.05) (Fig. 1A).

thumbnail
Download:
Figure 1. TGFβ1 decreases p27 phosphorylation at Thr187 in the gastric mucosa of 14-day-old rats during fasting.

(A) Representative immunoblotting for p27 and phospho-p27Thr187 in samples scraped from the gastric mucosa of suckling and fasted pups after 0, 2 and 14 h of PBS and TGFβ1 gavage (1.5 ng/g body weight). β-actin was used as loading control. Each band represents one animal and fold changes are shown as means ± SD for p27 levels and for the ratio of p-p27/p27. (n) = 3–4 pups/group. * P<0.05 when compared to the suckling group, # P<0.05 vs. respective PBS-treated group. Analyses were conducted in blots ran in triplicates. (B) Immunodetection of phospho-p27Thr187 in the gastric mucosa of fasted pups after 2 and 14 h of PBS and TGFβ1 gavage. Sections were counterstained with Mayer's Hematoxylin. The labeling index (LI) (%) was obtained as the number of phospho-p27Thr187 positive cells/total cells ×100. (n) = 4–5 pups/group. Bars represent means ± SD. * P<0.05 vs PBS control at 2 h; # P<0.05 vs. respective PBS-treated group.

https://doi.org/10.1371/journal.pone.0101965.g001

By checking phospho-p27Thr187 concentration at the intervals used for total p27 analyses, we detected that fasting increased phosphorylation, which reached a peak after 2 h of treatment (Fig. 1A). TGFβ1 gavage reversed this effect and reduced phospho-p27Thr187 level (Fig. 1A). In order to compare the rate of phosphorylation, we analysed phospho-p27Thr187/p27 ratio, and found that whereas fasting increased it after 2 h (P<0.05), TGF β1 reduced the ratio after 2 and 14 h of treatment when the respective counterparts were compared (P<0.05) (Fig. 1A).

Through morphological study, we observed that the nuclei immunostained for phospho-p27Thr187 were scattered along the gastric gland (Fig. 1B). The labelling index (LI) decreased significantly after TGFβ1 gavage (2 h) when compared to the PBS- correspondent group (P<0.05) (Fig. 1B). After 14 h of treatment, the LI was lower when compared to the PBS- counterpart at 2 h (P<0.05), indicating that the stimulatory effect of fasting on p27 phosphorylation was diminished. In addition, TGFβ1 was still active as immunostaining remained lower than the respective control group (P<0.05).

TGFβ1 and p27 regulators

Because we detected that TGFβ1 increased p27 levels and decreased its phosphorylation in the gastric mucosa, we also investigated whether cell-cycle related proteins involved in p27 stability would also be influenced by fasting and TGFβ1 gavage.

We found that Cyclin E, Cdk2 and Cdh1were not significantly affected by treatment (Fig. 2). However, we observed Skp2 augment after the onset of fasting when compared to suckling control group (P<0.05). TGFβ1 significantly reduced Skp2 after 14 h of administration (P<0.05).

thumbnail
Download:
Figure 2. TGFβ1 effects on p27 regulators in the gastric mucosa of 14-day-old rats during fasting.

Representative immunoblotting for Skp2, Cdh1, Cyclin E and Cdk2 proteins in the gastric mucosa of suckling and fasted pups after 0, 2 and 14β1 gavage. β-actin was used as loading control. Each band represents one animal and fold changes are shown as means ± SD for each protein. (n) = 3–4 pups/group. Analyses were conducted in blots ran in triplicates. * P<0.05 vs suckling group. # P<0.05 vs. respective PBS-treated group.

https://doi.org/10.1371/journal.pone.0101965.g002

Specific role of TGFβ1 on p27 levels

In order to evaluate the specific effect of exogenous TGFβ1 on p27 concentration and phosphorylation, we used an antibody against the peptide to neutralize its activity. We observed that TGFβ1 gavage increased p27 levels when compared to the group treated with PBS (P<0.05) (Fig. 3), as expected and shown above. When α-TGFβ1 was administrated together with the peptide (α-TGFβ1+TGFβ1) during fasting, p27 concentration decreased regarding TGFβ1 counterpart (P<0.05), and it was restored to the control levels (PBS- group), indicating the neutralization of TGFβ1 effects (Fig. 3).

thumbnail
Download:
Figure 3. TGFβ1 direct effects on p27 and phospho-p27Thr187 in the gastric mucosa of 14-day-old rats during fasting.

Representative immunoblotting for p27 and phospho-p27Thr187 in the gastric mucosa of pups fasted and gavaged with PBS, TGFβ1, α-TGFβ1 or TGFβ1+α-TGFβ1. All samples were collected after 2 h of treatment. β-actin was used as loading control. Each band represents one animal and fold changes are shown as means ± SD for p27 levels and for the ratio of p-p27/p27. (n) = 3 pups/group. * P<0.05 when compared to fasted-control group, # P<0.05 vs. respective counterpart. Analyses were conducted in blots ran in triplicates.

https://doi.org/10.1371/journal.pone.0101965.g003

Additionally, we compared the direct role of TGFβ1 on phosphorylation control, and after confirming that TGFβ1 gavage reduced phospho-p27Thr187 levels (P<0.05) (Fig. 3), we verified that the combined use of α-TGFβ1+TGFβ1 significantly increased phospho-p27Thr187/p27 ratio when TGFβ1- treated group was considered (P<0.05) (Fig. 3). Of note, for both total and phosphorylated proteins, the administration of α-TGFβ1 during fasting did not exert any response (Fig. 3)

TGFβ1 role on p27 expression and protein synthesis

In order to study p27 expression in the gastric mucosa of suckling rats submitted to fasting and TGFβ1 treatment (2 h), we used RT-PCR to detect it. As shown in Figure 4A, we did not observe significant differences, and so we did not conduct qRT- PCR analyses.

thumbnail
Download:
Figure 4. TGFβ1 effects on p27 expression and synthesis in the gastric mucosa of 14-day-old rats during fasting.

(A) p27 mRNA levels in the gastric mucosa of pups after 2 h of PBS and TGFβ1 gavage. β-actin was used as control. (n) = 5 pups at each condition. Analyses were performed in duplicates. (B) Immunoblotting for p27 protein levels in fasted pups treated as indicated with cycloheximide (CHX) to inhibit protein synthesis. All samples were collected after 2 h of treatment. β-actin was used as loading control. Each band represents one animal and fold changes are shown as means ± SD. (n) = 3 pups/group. * P<0.05 vs. fasted-control group; # P<0.05 vs. TGFβ1 group. Analyses were conducted in blots ran in triplicates.

https://doi.org/10.1371/journal.pone.0101965.g004

Next, to evaluate if TGFβ1 might be involved in the control of p27 translation, we administered cycloheximide (CHX) to the pups to inhibit protein synthesis. We confirmed that TGFβ1 increased p27 concentration during fasting (P<0.05) (Fig. 4B), and we found that CHX (TGFβ1+CHX) reduced p27 levels when compared to the group treated with the peptide (P<0.05) (Fig. 4B).

TGFβ1 role on p27 degradation

In order to understand how long it takes to the gastric mucosa to degrade p27 during fasting and after TGFβ1 gavage, we collected samples from pups treated for 2 h and prepared total protein lysates that were incubated for progressive periods in the presence of degradation buffer containing recombinant p27 (p27r) [34].

We observed that p27r was degraded in PBS- and TGFβ1- treated groups, as the decrease of p27 level was recorded for both conditions (P<0.05). However, higher concentrations of remaining p27r were detected in TGFβ1 samples when compared to the PBS counterparts after 3 and 6 h of degradation assay (P<0.05) (Fig. 5). Accordingly, we found that after 3 h of incubation, 69.6% of p27r were remaining in the lysates obtained from TGFβ1 group, whereas in PBS- gavaged pups, we recorded 55.5% from the initial p27r level (P<0.05). After 6 h, we detected 55.8% and 28% of remaining p27r, respectively in TGFβ1 and control pups (P<0.05) (Fig. 5).

thumbnail
Download:
Figure 5. TGFβ1 reduces p27 protein degradation in the gastric mucosa of 14-day-old fasted rats.

Immunoblotting for p27 during degradation assay, after 1, 30(p27r) protein. Samples were collected after 2 h of gavage with PBS or TGFβ1. The representative blots show the p27 band and a smear above it, which was derived from the degradation at each period of incubation. Each band represents one animal. Bars show the means ± SD of remaining p27r (%) based on relative density of each band over time compared with samples at 1 min. (n) = 4 pups at each condition. During the degradation assay, the % of remaining p27 decreased significantly in PBS- and TGFβ1- treated groups (P<0.05) (ANOVA). * P<0.05 for PBS vs. TGFβ1 treatment at 3 and 6 h of incubation. The assay was conducted in duplicates.

https://doi.org/10.1371/journal.pone.0101965.g005

Discussion

In the current study, we showed for the first time that luminal TGFβ1 increased p27 levels in the rat gastric mucosa through the regulation of protein synthesis and degradation. This result was achieved when we used fasting condition as a physiological model to stimulate the proliferation of gland cells in rat pups [38], [39] and to challenge TGFβ1 response [6]. But also as important, we demonstrated that food restriction promoted p27 degradation. It is well established that reduced levels of p27 are directly related to tumor growth and poor prognosis in several types of carcinomas, especially due to the escape of cell cycle control. Herein, we showed that the non-transformed gastric mucosa responded to the physiological stimulus of fasting and to TGFβ1, allowing the study of the molecular mechanism involved in gastric growth.

During postnatal development, gastric p27 concentration is modulated in response to feeding condition, dietary pattern, growth factors and hormones, and the changes reflect on cell proliferation regulation [6], [46]–[48]. We observed that in suckling rats, whereas p27 levels were high, phosphorylation at Thr187 was low. However, fasting increased phospho-p27Thr187/p27 ratio and decreased the total concentration of the CKI. In addition, the combined record of nuclear phospho-p27Thr187 immunolabeling and the high distribution of positive cells along the gland (which represents the proliferative compartment during the first weeks of postnatal development) [38], [40] indicated that food restriction was directing p27 to degradation and consequently, it promoted cell proliferation as previously described [6], [49], [50]. Although previous reports have discussed the importance of p27 decrease during late G1 phase in multiple cell types submitted to different pro- proliferative stimuli in vitro [26], [31], [33], [51], [52], this is the first study to focus on the effects promoted by fasting condition on p27 phosphorylation and degradation in vivo.

During fasting, the components of meal are depleted from luminal content and the digestive metabolism is low, but interestingly, during suckling phase, food restriction also represents the lack of TGFβ and other milk-born growth factors. In addition, the gastric mucosa produces low levels of TGFβ1 and TGFβ3 [22]. De Andrade Sá et al. (2008) showed that the gavage of TGFβ1 during fasting inhibits gastric cell proliferation and induces apoptosis in the presence of high p27 levels [6]. We confirmed that TGFβ1 increased the concentration of p27, but we further observed that TGFβ1 reversed fasting- induced p27 phosphorylation, which might contribute to the low proliferative rates, previously described for this condition. Moreover, we demonstrated that these responses were specifically triggered by gavaged- TGFβ1 as indicated after the experiments with anti- TGFβ1. Accordingly, we showed that the neutralizing antibody was effective only when combined with the growth factor, suggesting that exogenous TGFβ1 had a direct role on the epithelium. Milk- born TGFβ was firstly studied in the 1990's [14], [15], when both the stability of the peptide and its effects were characterized. Of note, while rat pups remain suckling, growth factors from milk are available and active [16], [17], [53], and we currently showed that the exogenous TGFβ1 was able to specifically regulate p27 levels. Such results add important data to the understanding of TGFβ1 roles during gastric ontogenesis and cell cycle control.

Next, we investigated whether different molecules involved in the regulation of p27 levels and activity would be altered by fasting and TGFβ1 treatment. As Cyclin E/Cdk2 complex is part of the machinery required for p27 phosphorylation [27], [28], [49], we first checked for their concentration, and we observed that Cyclin E and Cdk2 were not influenced. This result corroborated previous studies that demonstrated that neither fasting nor early weaning changed the expression of these molecules [6], [46], [47]. However, because it was shown that gavage with TGFβ1 during fasting promoted a higher interaction between p27 and Cyclin E [6], we further evaluated other elements that might be involved in p27 degradation.

SCF E3 ligase complex is known to promote the degradation of cell cycle proteins and Skp2 is the nuclear adaptor responsible for the ubiquitylation of phospho-p27 and ultimately its degradation via proteasome [54]–[57]. The analysis of 98 patients with gastric carcinoma showed that tumors have a high expression of Skp2, which is inversely correlated to p27 levels [58], [59]. We detected that fasting induced a rapid increase in Skp2 concentration, and TGFβ1 might alter such response by decreasing Skp2 levels after 14 h of treatment. We also evaluated Cdh1 (APC/CCdh1 complex targets Skp2) [60], [61], which promotes the accumulation of p27 [62], [63]. In colorectal carcinoma, concentrations of Cdh1 and p27 are very low when compared to healthy surrounding tissue, while the expression of Skp2 is inversely higher [64]. Our results were not significantly different, but they show a slight variation of this protein.

We checked for p27 expression and protein synthesis in the gastric mucosa, and found that only this latter process was modified by TGFβ1 gavage during fasting. These results are in agreement with other studies that suggest that p27 expression is not altered during treatment with TGFβ1 and indicate a post-transcriptional control [34], [50], [65]. If we consider the mechanisms that might be involved in the control of p27 translation, we can speculate about the role of miR- 221 and miR- 222. They control the p27-3′UTR region [66], repress the sensitivity to TGFβ and increase proliferation in breast cancer cells [66], [67]. Moreover, miR- 221 has been associated to a poor prognosis in gastric cancer [68].

Up to this point, we had demonstrated that TGFβ1 increased p27 levels by decreasing the phosphorylation at Thr187, and it did not affect expression, while synthesis was slightly altered. In 1995, Pagano et al. were able to monitor the degradation of p27, and they noted that proliferating cells broke this CKI more rapidly than the quiescent ones [26]. By using a similar assay [34] we observed that samples collected from the gastric mucosa of pups gavaged with TGFβ1 degraded a smaller amount of p27 at a slower rate when compared to fasted-control group. Such results suggested that TGFβ1 increased p27 stability, which might be directly involved in cell proliferation control in the gastric epithelium [6]. Conversely, fasting induced p27 cleavage, creating a proper condition for cell cycle progression. Similar data were described for endometrial glands at different physiological phases and in tumors [34].

Altogether, we demonstrated that the presence of TGFβ1 in the gastric lumen was able to increase p27 synthesis and also to reduce its phosphorylation at Thr187 and final degradation. We concluded that during gastric postnatal development, the regulation of p27 protein concentration represents one of the mechanisms used by rapidly proliferating cells to respond to milk-born TGFβ1 and food restriction. Hence, we suggest that the suckling period can be an important window of gastric growth to study the major apparatus involved in epithelial cycle control, which will dually govern both ontogenesis and tumorigenesis.

Acknowledgments

We thank Cruz Alberto Mendoza Rigonati for the technical assistance and Eunice Ribeiro de Andrade Sá for designing part of the experiments.

Author Contributions

Conceived and designed the experiments: PG APZPF. Performed the experiments: APZPF LHO. Analyzed the data: APZPF LHO PG. Contributed reagents/materials/analysis tools: PG. Contributed to the writing of the manuscript: APZPF LHO PG.

References

  1. 1. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105: 1039–1045.
  2. 2. Massague J (2012) TGF-beta signaling in development and disease. FEBS Lett 586: 1833.
  3. 3. Barnard JA, Beauchamp RD, Coffey RJ, Moses HL (1989) Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci U S A 86: 1578–1582.
  4. 4. Rokutan K, Yamada M, Torigoe J, Saito T (1998) Transforming growth factor-beta inhibits proliferation and maturation of cultured guinea pig gastric pit cells. Am J Physiol 275: G526–533.
  5. 5. Booth D, Haley JD, Bruskin AM, Potten CS (2000) Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer 86: 53–59.
  6. 6. de Andrade Sa ER, Bitencourt B, Alvares EP, Gama P (2008) In vivo effects of TGFbeta1 on the growth of gastric epithelium in suckling rats. Regul Pept 146: 293–302.
  7. 7. Nam KT, O'Neal R, Lee YS, Lee YC, Coffey RJ, et al. (2012) Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature. Lab Invest 92: 883–895.
  8. 8. de Andrade Sa ER, Jordao LR, Takahashi CA, Alvares EP, Gama P (2003) Ontogenic expression of TGFbeta 1, 2, and 3 and its receptors in the rat gastric mucosa. Dev Dyn 227: 450–457.
  9. 9. Fujisawa T, Kamimura H, Hosaka M, Torii S, Izumi T, et al. (2004) Functional localization of proprotein-convertase furin and its substrate TGFbeta in EGF receptor-expressing gastric chief cells. Growth Factors 22: 51–59.
  10. 10. Kannan A, Krishnan A, Ali M, Subramaniam S, Halagowder D, et al. (2014) Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition. Eur J Cancer 50: 204–215.
  11. 11. Voon DC, Wang H, Koo JK, Nguyen TA, Hor YT, et al. (2012) Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells 30: 2088–2099.
  12. 12. Ciacci C, Lind SE, Podolsky DK (1993) Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105: 93–101.
  13. 13. Tsutsumi S, Tomisato W, Hoshino T, Tsuchiya T, Mizushima T (2002) Transforming growth factor-beta1 is responsible for maturation-dependent spontaneous apoptosis of cultured gastric pit cells. Exp Biol Med (Maywood) 227: 402–411.
  14. 14. Saito S, Yoshida M, Ichijo M, Ishizaka S, Tsujii T (1993) Transforming growth factor-beta (TGF-beta) in human milk. Clin Exp Immunol 94: 220–224.
  15. 15. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, et al. (1994) Maternal rescue of transforming growth factor-beta 1 null mice. Science 264: 1936–1938.
  16. 16. Penttila IA, van Spriel AB, Zhang MF, Xian CJ, Steeb CB, et al. (1998) Transforming growth factor-beta levels in maternal milk and expression in postnatal rat duodenum and ileum. Pediatr Res 44: 524–531.
  17. 17. Nakamura Y, Miyata M, Ando T, Shimokawa N, Ohnuma Y, et al. (2009) The latent form of transforming growth factor-beta administered orally is activated by gastric acid in mice. J Nutr 139: 1463–1468.
  18. 18. Shen Z, Kauttu T, Cao J, Seppanen H, Vainionpaa S, et al. (2013) Macrophage coculture enhanced invasion of gastric cancer cells via TGF-beta and BMP pathways. Scand J Gastroenterol 48: 466–472.
  19. 19. Wu WK, Cho CH, Lee CW, Fan D, Wu K, et al. (2010) Dysregulation of cellular signaling in gastric cancer. Cancer Lett 295: 144–153.
  20. 20. Naef M, Ishiwata T, Friess H, Buchler MW, Gold LI, et al. (1997) Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer 71: 131–137.
  21. 21. Ogias D, de Andrade Sa ER, Alvares EP, Gama P (2010) Opposite effects of fasting on TGF-beta3 and TbetaRI distribution in the gastric mucosa of suckling and early weanling rats. Nutrition 26: 224–229.
  22. 22. Alvares EP, Jordao LR, Gama P (2007) Differential distribution of transforming growth factor beta and receptors in the hyper or hypoproliferative gastric mucosa of developing and adult rats. Histol Histopathol 22: 147–153.
  23. 23. Myung N, Kim MR, Chung IP, Kim H, Jang JJ (2000) Loss of p16 and p27 is associated with progression of human gastric cancer. Cancer Lett 153: 129–136.
  24. 24. Kuzushita N, Rogers AB, Monti NA, Whary MT, Park MJ, et al. (2005) p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 129: 1544–1556.
  25. 25. Wen S, So Y, Singh K, Slingerland JM, Resnick MB, et al. (2012) Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer. Oncogene 31: 1771–1780.
  26. 26. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, et al. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682–685.
  27. 27. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, et al. (1999) Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 13: 1181–1189.
  28. 28. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE (1997) Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 11: 1464–1478.
  29. 29. Hengst L, Reed SI (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861–1864.
  30. 30. Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193–199.
  31. 31. Auld CA, Fernandes KM, Morrison RF (2007) Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia. J Cell Physiol 211: 101–111.
  32. 32. Frescas D, Pagano M (2008) Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8: 438–449.
  33. 33. Pavlides SC, Huang KT, Reid DA, Wu L, Blank SV, et al. (2013) Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Endocrinology 154: 4030–4045.
  34. 34. Lecanda J, Parekh TV, Gama P, Lin K, Liarski V, et al. (2007) Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Res 67: 1007–1018.
  35. 35. Ciarallo S, Subramaniam V, Hung W, Lee JH, Kotchetkov R, et al. (2002) Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. Mol Cell Biol 22: 2993–3002.
  36. 36. Pillaire MJ, Casagrande F, Malecaze F, Manenti S, Darbon JM (1999) Regulation by transforming growth factor-beta 1 of G1 cyclin-dependent kinases in human retinal epithelial cells. Exp Eye Res 68: 193–199.
  37. 37. Wang W, Ungermannova D, Jin J, Harper JW, Liu X (2004) Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. Oncogene 23: 1064–1075.
  38. 38. Alvares EP (1992) The effect of fasting on cell proliferation in the gastric mucosa of the 14-day-old suckling rat. Braz J Med Biol Res 25: 641–649.
  39. 39. Gama P, Alvares EP (1998) Corticosterone treatment inhibits cell proliferation in the gastric epithelium of suckling rats. J Gastroenterol 33: 32–38.
  40. 40. Alvares EP, Gama P (1993) Fasting enhances cell proliferation of gastric epithelium during the suckling period in rats. Braz J Med Biol Res 26: 869–873.
  41. 41. Playford RJ, Floyd DN, Macdonald CE, Calnan DP, Adenekan RO, et al. (1999) Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44: 653–658.
  42. 42. Deneme MA, Ok E, Akcan A, Akyildiz H, Soyuer I, et al. (2006) Single dose of anti-transforming growth factor-beta1 monoclonal antibody enhances liver regeneration after partial hepatectomy in biliary-obstructed rats. J Surg Res 136: 280–287.
  43. 43. Mierzejewski P, Siemiatkowski M, Radwanska K, Szyndler J, Bienkowski P, et al. (2006) Cycloheximide impairs acquisition but not extinction of cocaine self-administration. Neuropharmacology 51: 367–373.
  44. 44. Torquati A, O'rear L, Longobardi L, Spagnoli A, Richards WO, et al. (2004) RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. Surgery 136: 310–316.
  45. 45. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
  46. 46. Osaki LH, Figueiredo PM, Alvares EP, Gama P (2011) EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats. Cell Prolif 44: 174–182.
  47. 47. Ogias D, de Andrade Sa ER, Kasai A, Moisan MP, Alvares EP, et al. (2010) Fasting differentially regulates plasma corticosterone-binding globulin, glucocorticoid receptor, and cell cycle in the gastric mucosa of pups and adult rats. Am J Physiol Gastrointest Liver Physiol 298: G117–125.
  48. 48. Osaki LH, Gama P (2013) MAPK Signaling Pathway Regulates p27 Phosphorylation at Threonin 187 as Part of the Mechanism Triggered by Early-Weaning to Induce Cell Proliferation in Rat Gastric Mucosa. PLoS One 8: e66651.
  49. 49. Bloom J, Pagano M (2003) Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 13: 41–47.
  50. 50. Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, et al. (2002) Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res 62: 2778–2790.
  51. 51. Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, et al. (1999) Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274: 13886–13893.
  52. 52. Huang KT, Pavlides SC, Lecanda J, Blank SV, Mittal KR, et al. (2012) Estrogen and Progesterone Regulate p27kip1 Levels via the Ubiquitin-Proteasome System: Pathogenic and Therapeutic Implications for Endometrial Cancer. PLoS One 7: e46072.
  53. 53. Koldovsky O, Illnerova H, Macho L, Strbak V, Stepankova R (1995) Milk-borne hormones: possible tools of communication between mother and suckling. Physiol Res 44: 349–351.
  54. 54. Lu Z, Hunter T (2010) Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell Cycle 9: 2342–2352.
  55. 55. Lipkowitz S, Weissman AM (2011) RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer 11: 629–643.
  56. 56. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H (1999) p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 9: 661–664.
  57. 57. Starostina NG, Kipreos ET (2012) Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol 22: 33–41.
  58. 58. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, et al. (2002) Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62: 3819–3825.
  59. 59. Zhu L (2010) Skp2 knockout reduces cell proliferation and mouse body size: and prevents cancer? Cell Res 20: 605–607.
  60. 60. Qiao X, Zhang L, Gamper AM, Fujita T, Wan Y (2010) APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity. Cell Cycle 9: 3904–3912.
  61. 61. Skaar JR, Pagano M (2009) Control of cell growth by the SCF and APC/C ubiquitin ligases. Curr Opin Cell Biol 21: 816–824.
  62. 62. Li M, Shin YH, Hou L, Huang X, Wei Z, et al. (2008) The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory. Nat Cell Biol 10: 1083–1089.
  63. 63. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, et al. (2004) Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428: 194–198.
  64. 64. Fujita T, Liu W, Doihara H, Wan Y (2008) Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am J Pathol 173: 217–228.
  65. 65. Lecanda J, Ganapathy V, D'Aquino-Ardalan C, Evans B, Cadacio C, et al. (2009) TGFbeta prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest. Cell Cycle 8: 742–756.
  66. 66. Kedde M, van Kouwenhove M, Zwart W, Oude Vrielink JA, Elkon R, et al. (2010) A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol 12: 1014–1020.
  67. 67. Rao X, Di Leva G, Li M, Fang F, Devlin C, et al. (2011) MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30: 1082–1097.
  68. 68. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, et al. (2012) Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 7: e33608.